Cite
HARVARD Citation
Novoplansky, O. et al. (2019). MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer. International journal of cancer. 145 (3), pp. 748-762. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Novoplansky, O. et al. (2019). MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer. International journal of cancer. 145 (3), pp. 748-762. [Online].